Goldman Sachs Group Inc Spring Works Therapeutics, Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,275,449 shares of SWTX stock, worth $107 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,275,449
Previous 626,095
263.44%
Holding current value
$107 Million
Previous $27.6 Million
287.0%
% of portfolio
0.02%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding SWTX
# of Institutions
277Shares Held
73.1MCall Options Held
12MPut Options Held
1.39M-
Vanguard Group Inc Valley Forge, PA7.13MShares$335 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$264 Million0.0% of portfolio
-
Glazer Capital, LLC New York, NY4.11MShares$193 Million6.9% of portfolio
-
Fil LTD Hamilton, D03.01MShares$142 Million0.13% of portfolio
-
State Street Corp Boston, MA2.99MShares$141 Million0.01% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.93B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...